Law firm investigates Fulgent Genetics for potential securities law violations after revenue miss.

Lowey Dannenberg, P.C. is investigating Fulgent Genetics, Inc. for possible violations of federal securities laws following the company's report of 2025 revenue slightly below guidance and a sequential decline in Q4 revenue. The law firm is encouraging investors who suffered losses in Fulgent securities to contact them for potential legal action. This investigation highlights concerns about the company's financial disclosures and may lead to legal proceedings if violations are confirmed.